Interleukin-1 receptor antagonist

被引:54
作者
Bresnihan, B
Cunnane, G
机构
[1] St Vincents Hosp, Dublin 4, Ireland
[2] Univ Coll, Dublin, Ireland
关键词
D O I
10.1016/S0889-857X(05)70029-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
There are three members of the IL-1 gene family: IL-1 alpha, IL-1 beta, and IL-1ra. IL-1 alpha and IL-1 beta are both antagonist molecules with many proinflammatory effects. IL-1ra is an antagonist molecule that can inhibit the effect of IL-1 alpha and IL-1 beta by specifically blocking the IL-1 receptor on target effector cells. IL-1 alpha and IL-1 beta are considered to be pivotal cytokines in the pathogenesis of many inflammatory diseases. Anti-IL-1 treatment has been shown to cause amelioration of arthritis in animal models and in RA, suggesting that IL-1ra may be an important therapeutic option in the future management of RA.
引用
收藏
页码:615 / +
页数:15
相关论文
共 70 条
  • [11] Dose-range and dose-frequency study of recombinant human interleukin-1 receptor antagonist in patients with rheumatoid arthritis
    Campion, GV
    Lebsack, ME
    Lookabaugh, J
    Gordon, G
    Catalano, M
    Borenstein, D
    Caldwell, J
    Cohen, SA
    Cohen, SB
    Fleischmann, R
    Heller, MD
    Howard, P
    Jaffer, AM
    Kaine, JL
    Kitsis, E
    Kopp, EJ
    Moreland, LW
    OHanlan, M
    Prupas, M
    Rosenberg, A
    Rutstein, J
    Sack, MR
    Schiff, MH
    Singleton, CM
    Taborn, J
    Tindall, E
    Weaver, AL
    Yocum, D
    [J]. ARTHRITIS AND RHEUMATISM, 1996, 39 (07): : 1092 - 1101
  • [12] Cauli A, 1997, BRIT J RHEUMATOL, V36, P935
  • [13] CHANG DM, 1992, J RHEUMATOL, V19, P1678
  • [14] CHOMARAT P, 1995, J IMMUNOL, V154, P1432
  • [15] CHU CQ, 1992, BRIT J RHEUMATOL, V31, P653
  • [16] Cunnane G., 1996, Arthritis and Rheumatism, V39, pS245
  • [17] DANIS VA, 1990, CLIN EXP IMMUNOL, V79, P335
  • [18] DELEURAN BW, 1992, BRIT J RHEUMATOL, V31, P801
  • [19] Biologic basis for interleukin-1 in disease
    Dinarello, CA
    [J]. BLOOD, 1996, 87 (06) : 2095 - 2147
  • [20] DINARELLO CA, 1993, NEW ENGL J MED, V328, P106